ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1898

Type I Interferon-Induced Proteins May Facilitate the Occurrence of Long QT Syndrome (LQTS) in Parallel with Anti-Ro/SSA and Anti-Ro52/TRIM21 Antibody Levels in Patients with Systemic Lupus Erythematous (SLE): A Bench to Bedside Approach

Luis F. Perez-Garcia1,2, Irving O. Estevez-Garcia3, Ricardo Marquez-Velasco3, Pedro Iturralde4, Luis H. Silveira5 and Luis M. Amezcua-Guerra2,6,7, 1Rheumatology, Erasmus MC, Rotterdam, Netherlands, 2Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, 3Immunology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, 4Cardiology - Electrophysiology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, 5Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City DF, Mexico, 6Cardiovascular Research Laboratory, Unidad de Investigacion Traslacional, Universidad Nacional Autonoma de Mexico/Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, 7Department of Health Care, Universidad Autonoma Metropolitana, Xochimilco, Mexico City, Mexico

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Antibodies, cytokines and heart block, Lupus

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Monday, October 22, 2018

Session Title: 4M108 ACR Abstract: SLE–Etiology & Pathogenesis I (1893–1898)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Long QT syndrome (LQTS) is an abnormal QT corrected (QTc) interval prolongation, strongly associated with increased risk of sudden death. Studies have associated LQTS with autoimmune conditions, and evidence points towards a link between inflammation and LQTS. We already demonstrated that LQTS occurs in SLE patients positive to anti-Ro/SSA antibodies, and interference with ventricular repolarization is linearly associated with levels of anti-Ro52/TRIM21 antibodies. However, critical cytokine pathways facilitating the development of LQTS in SLE are still unknown. This study was conducted to evaluate the cytokine milieu in SLE patients with LQTS.

Methods: Consecutive patients fulfilling the 1997 ACR criteria for SLE were included. Patients with a history of ischemic heart disease or implantable pacemakers, and those taking drugs potentially affecting QT interval (except for antimalarials) were excluded. Patients underwent a resting 12-lead ECG recording to measure QTc interval (Bazzet’s formula). A QTc interval duration >460 msec in women and >440 msec in men was set to define LQTS. Serum cytokine and chemokine levels were measured by multiplex bead array technology.

Results: Sixty-six patients with a mean age of 39±13 years (57 female gender) were included. A LQTS was found in 10 patients (15%), with mean QTc interval of 470±18 msec as compared to 414±23 msec in those with no LQTS. Main clinical and demographic characteristics were similar in both groups, except for a lesser use of antimalarials in patients with LQTS. Disease activity was similar between groups. Anti-Ro/SSA (75±66 U/mL versus 29±44 U/mL; P=0.005) and anti-Ro52/TRIM21 (50±55 U/mL versus 14±30 U/mL; P=0.01) antibody levels were higher in patients with LQTS.

Regarding serum cytokines, levels of type I IFN-induced chemokines IP-10 (425±258 pg/mL versus 275±267 pg/mL; P=0.021) and IL-8 (58±52 pg/mL versus 29±24 pg/mL; P=0.039) were significantly higher in patients with LQTS. Notably, anti-Ro/SSA antibody levels were linearly associated with IP-10 (r=0.41, 95%CI 0.18–0.60; P=0.0002) and IL-8 (r=0.31, 0.06–0.52; P=0.005) levels. In addition, anti-Ro52/TRIM21 antibody levels also were linearly correlated with IP-10 (r=0.39, 0.16–0.58; P=0.0005) and IL-8 (r=0.23, -0.02–0.45; P=0.03) levels. Other type I IFN-induced chemokines (MCP-1 and RANTES) were similar between groups.

No differences in the cytokine circuits characterizing Th1 (IFN-g, IL-2, IL-12, IL-27), Th2 (IL-4, IL-5, IL-13, IL-6), Th17 (IL-17, IL-21, IL-22, IL-6, GM-CSF, IL-23), Th9 (IL-9, IL-4, IL-21, IL-6), Th22 (IL-22, TNF, IL-6, IL-10), Tr1 (IL-10, IFN-g, IL-27) were found. Additionally, no differences were found in other chemokines (MIP-1α, SDF-1, IL-18, GRO-α, Eotaxin, MIP-1β) characteristic of innate immunity.

Conclusion: Our results reinforce the existence of a specific LQTS mediated by anti-Ro/SSA autoantibodies, especially those specifically directed against the antigen Ro52/TRIM21. The interference in ventricular repolarization seems to be driven by proteins from the IFN gene signature, which is in line with the notion that Ro52/TRIM21 antigens are an element of response to type I IFN.


Disclosure: L. F. Perez-Garcia, None; I. O. Estevez-Garcia, None; R. Marquez-Velasco, None; P. Iturralde, None; L. H. Silveira, None; L. M. Amezcua-Guerra, None.

To cite this abstract in AMA style:

Perez-Garcia LF, Estevez-Garcia IO, Marquez-Velasco R, Iturralde P, Silveira LH, Amezcua-Guerra LM. Type I Interferon-Induced Proteins May Facilitate the Occurrence of Long QT Syndrome (LQTS) in Parallel with Anti-Ro/SSA and Anti-Ro52/TRIM21 Antibody Levels in Patients with Systemic Lupus Erythematous (SLE): A Bench to Bedside Approach [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10). https://acrabstracts.org/abstract/type-i-interferon-induced-proteins-may-facilitate-the-occurrence-of-long-qt-syndrome-lqts-in-parallel-with-anti-ro-ssa-and-anti-ro52-trim21-antibody-levels-in-patients-with-systemic-lupus-erythemato/. Accessed April 16, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/type-i-interferon-induced-proteins-may-facilitate-the-occurrence-of-long-qt-syndrome-lqts-in-parallel-with-anti-ro-ssa-and-anti-ro52-trim21-antibody-levels-in-patients-with-systemic-lupus-erythemato/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.